We serve Chemical Name:2,2′,3,3′,5,6-Hexachlorobiphenyl CAS:52704-70-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,2′,3,3′,5,6-Hexachlorobiphenyl
CAS.NO:52704-70-8
Synonyms:1,2,4,5-tetrachloro-3-(2,3-dichlorophenyl)benzene
Molecular Formula:C12H4Cl6
Molecular Weight:360.87800
HS Code:2903999090
Physical and Chemical Properties:
Melting point:100°C
Boiling point:387.4ºC at 760 mmHg
Density:1.593 g/cm3
Index of Refraction:1.626
PSA:
Exact Mass:357.84400
LogP:7.27400
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,2,4,5-tetrachloro-3-(2,3-dichlorophenyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2,4,5-tetrachloro-3-(2,3-dichlorophenyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,4,5-tetrachloro-3-(2,3-dichlorophenyl)benzene Use and application,1,2,4,5-tetrachloro-3-(2,3-dichlorophenyl)benzene technical grade,usp/ep/jp grade.
Related News: J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. 2,2′,3,3′,5,6-Hexachlorobiphenyl manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. 2,2′,3,3′,5,6-Hexachlorobiphenyl supplier From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. 2,2′,3,3′,5,6-Hexachlorobiphenyl vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. 2,2′,3,3′,5,6-Hexachlorobiphenyl factory J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed.
